Harnessing Mosquito Immunity
To Curtail Arboviral Disease Transmission
Why Mosquito Is The Deadliest Animal In The World
80%
of the world's population is at risk of one or more
vector-borne disease
17%
of the global burden of communicable diseases is due to vector-borne diseases
>700,000
deaths are caused by vector-borne diseases annually
Vector Identification
Morphological & Molecular Biomarker-Based
We provide species identification of arthropod vector (e.g., mosquitoes, ticks) across various developmental stages (e.g., larvae, nymphs, pupae, adults) through integrated methodologies: morphological taxonomy and molecular identification utilizing PCR amplification of key biomarkers (e.g.,COI, ITS2, 16S).
In Vivo Mosquito Insecticide Resistance Testing
We perform localized assessments of mosquito susceptibility/resistance to public health insecticides (pyrethroids, organophosphates, carbamates) using WHO-standardized bioassays (adult tube tests, larval susceptibility assays). Our data-driven approach supports targeted vector control strategies with actionable insights.
Molecular Screening and Surveillance
Of Vector-Borne Pathogens and Vector Species
We provide extensive detection platform for arbovirus, vector-borne pathogens and zoonotic pathogens from vector species and other animals and environmental samples, based on advanced sample collection methods (e.g., passive traps and professional surveillance personnel) and molecular screening technologies (e.g., PCR, INAAT, ELISA, and NGS). We also provide data analysis service for risk assessment of arbovirus, vector-borne pathogens and zoonotic pathogens.
About
Story
C2iVect was established as an innovative spin-off from the Centre for Immunology & Infection (C2i), driven by the need to address vector-borne diseases. Drawing on the expertise and research of C2i, C2iVect specializes in advanced vector identification, insecticide resistance testing, and molecular pathogen surveillance.
Vision
At C2iVect, our vision is to lead in vector control and public health through advanced science and technology. We focus on precise vector identification and rigorous insecticide resistance testing, empowering communities with targeted strategies against vector-borne diseases.
By employing innovative molecular screening and surveillance methods, we strive to enhance the understanding of disease dynamics, ultimately safeguarding public health to advance disease prevention efforts worldwide.